Apyx Medical Published Study on Renuvion Skin Technology

The Clearwater-based company reported clinical results showing improvements in skin quality markers.

Updated on Sept. 29, 2026 in Beauty

Bold vector editorial illustration showing a stylized cross-section of skin tissue, depicting scientific research on skin quality improvement.
Apyx Medical published a clinical study on Tuesday showing that its helium plasma radiofrequency technology produces measurable skin quality improvements in patients. AI Illustration. Upload story photo >

Live Poll

Do you trust clinical studies funded by manufacturers to demonstrate the safety of cosmetic procedures?

Apyx Medical has released findings from a clinical study demonstrating that its Renuvion helium plasma radiofrequency technology effectively improves skin quality. The research evaluated biological markers in patients following lower rhytidectomy surgery.

Why it matters

The study provides scientific evidence for the impact of this radiofrequency technology on subdermal tissue, helping to quantify its effects on skin health and inflammation. These results offer a clearer look at how such treatments influence cellular structure after surgical procedures.

The clinical study observed a 55% increase in elastin staining intensity and a 27% increase in elastin expression among the six participants. All 100% of the individuals involved in the study reported satisfaction with their final treatment outcomes.

The players

Apyx Medical

This Clearwater-based medical technology company specializes in the development and manufacturing of helium plasma radiofrequency products.

The details

Researchers conducted the study across two U.S. sites, evaluating tissue samples from patients who underwent lower rhytidectomy surgery. By comparing Renuvion-treated areas to untreated internal control zones, the team measured specific biological improvements in skin quality after the 180-day period.

Timeline

  1. September 29, 2026: Apyx Medical announced the clinical study results.

  2. Day 180: The study team completed final measurements for all participants.

Culture Shift

This study aligns with the broader medical trend of applying rigorous biological and cellular analysis to cosmetic procedures. It reflects an industry-wide move toward providing quantifiable, data-backed evidence for non-invasive and surgical aesthetic technologies.

Patients considering facial rejuvenation may use this data to discuss specific tissue-level outcomes with their medical providers. This research helps clarify the biological changes expected from the Renuvion treatment process for those undergoing rhytidectomy surgery.

The takeaway

This study highlights the shift toward using clinical markers like elastin density to measure the success of cosmetic technologies. Patients looking into such procedures should consult with their doctors to understand how these findings apply to their specific health goals.

Further reading

For more information on the latest advancements in skin treatments, explore our Beauty section.

More information

To review the full product details, visit the Renuvion product information page.

Live Poll

Do you trust clinical studies funded by manufacturers to demonstrate the safety of cosmetic procedures?